Oxy210, a novel inhibitor of hedgehog and TGF‐β signalling, ameliorates hepatic fibrosis and hypercholesterolemia in mice

Simon T. Hui(University of California, Los Angeles), Aldons J. Lusis(ABT Molecular Imaging (United States))
Endocrinology Diabetes & Metabolism
August 31, 2021
Cited by 24


Related Papers